NEW YORK, Oct 19 – Human Genome Sciences said Thursday that it would issue a public offering of 8,000,000 additional shares of its common stock, plus up to 1,200,000 shares to cover over-allotments, if any.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.